The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
903066633 9030666 33 F 20120720 20160713 20130122 20160714 EXP CA-ROCHE-1098537 ROCHE 29.46 YR F Y 129.00000 KG 20160714 MD CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
903066633 9030666 1 PS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) B20071,B20151,B20131,B20102,B20112, 125276 8 MG/KG INFUSION
903066633 9030666 2 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) B20071,B20151,B20131,B20102,B20112, 125276 680 MG INFUSION
903066633 9030666 3 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) MOST RECENT DOSE- 14/NOV/2014, 06/JAN/2015, 03/FEB/2015, AND 03/MAR2015. B20071,B20151,B20131,B20102,B20112, 125276 800 MG INFUSION
903066633 9030666 4 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) B20071,B20151,B20131,B20102,B20112, 125276 616 MG INFUSION
903066633 9030666 5 SS Amitriptyline AMITRIPTYLINE 1 Unknown U 0
903066633 9030666 6 SS ACTEMRA TOCILIZUMAB 1 Subcutaneous 125472 162 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE /wk
903066633 9030666 7 C TRAMADOL. TRAMADOL 1 0
903066633 9030666 8 C NAPROXEN. NAPROXEN 1 0
903066633 9030666 9 C OMEPRAZOLE. OMEPRAZOLE 1 0
903066633 9030666 10 C VITAMIN A VITAMIN A 1 0
903066633 9030666 11 C VITAMIN B12 CYANOCOBALAMIN 1 0
903066633 9030666 12 C DEVIL'S CLAW HERBALS 1 0
903066633 9030666 13 C METHOTREXATE. METHOTREXATE 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
903066633 9030666 1 Rheumatoid arthritis
903066633 9030666 5 Rheumatoid arthritis
903066633 9030666 6 Rheumatoid arthritis

Outcome of event

Event ID CASEID OUTC COD
903066633 9030666 HO
903066633 9030666 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
903066633 9030666 Anaemia
903066633 9030666 Anal fissure
903066633 9030666 Arthralgia
903066633 9030666 Blood pressure increased
903066633 9030666 Bronchitis
903066633 9030666 Choking sensation
903066633 9030666 Diarrhoea
903066633 9030666 Disorientation
903066633 9030666 Dizziness
903066633 9030666 Drug ineffective
903066633 9030666 Euphoric mood
903066633 9030666 Gait disturbance
903066633 9030666 Heart rate increased
903066633 9030666 Helicobacter infection
903066633 9030666 Hernia
903066633 9030666 Hypertension
903066633 9030666 Malaise
903066633 9030666 Nasopharyngitis
903066633 9030666 Oxygen saturation decreased
903066633 9030666 Pain
903066633 9030666 Pyrexia
903066633 9030666 Sinusitis
903066633 9030666 Tooth disorder
903066633 9030666 Tooth infection
903066633 9030666 Weight decreased
903066633 9030666 Weight increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
903066633 9030666 1 20120402 0
903066633 9030666 2 20121029 0
903066633 9030666 3 20131119 0
903066633 9030666 4 20120518 20160105 0
903066633 9030666 6 20160202 201605 0